<?xml version="1.0" encoding="UTF-8"?>
<ref id="B137">
 <label>137</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kamar</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Abravanel</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Behrendt</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Hofmann</surname>
    <given-names>J, Pageaux GP, Barbet C, Moal V, Couzi L, Horvatits T, De Man RA, Cassuto E, Elsharkawy AM, Riezebos-Brilman A, Scemla A, Hillaire S, Donnelly MC, Radenne S, Sayegh J, Garrouste C, Dumortier J, Glowaki F, Matignon M, Coilly A, Figueres L, Mousson C, Minello A, Dharancy S, Rerolle JP, Lebray P, Etienne I, Perrin P, Choi M, Marion O, Izopet J, Hepatitis E Virus Ribavirin Study Group</given-names>
   </name>
  </person-group>
  <article-title>Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study</article-title>
  <source>Clinical Infectious Diseases</source>
  <year>2019</year>
  <pub-id pub-id-type="doi">10.1093/cid/ciz953</pub-id>
 </element-citation>
</ref>
